TrialInternational journal of hematology2013

Combination of high-dose melphalan and bortezomib as conditioning regimen for autologous peripheral blood stem cell transplantation in multiple myeloma.

Toshihiro Miyamoto et al.PubMed ↗Publisher ↗

No numbers read from the abstract.